Dearborn Partners LLC Jazz Pharmaceuticals PLC Transaction History

Dearborn Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$129.72 - $159.85 $166,430 - $205,087	1,283 New	1,283 $204,000
Q1 2022 May 04, 2022	BUY	$129.64 - $160.7 $175,402 - $217,427	1,353 New	1,353 $211,000
Q3 2021 Oct 27, 2021	SELL	$128.64 - $184.79 $174,049 - $250,020	-1,353 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$150.19 - $173.5 $120,152 - $138,800	-800 Reduced 37.16%	1,353 $222,000
Q1 2020 May 11, 2020	BUY	$87.74 - $152.74 $35,096 - $61,096	400 Added 22.82%	2,153 $215,000
Q2 2017 Aug 09, 2017	BUY	N/A	1,753	1,753 $273,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Dearborn Partners LLC with notifications on news.